Your browser doesn't support javascript.
loading
A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and Posaconazole to Predict CYP3A4-Mediated Drug-Drug Interaction Frequently Observed in Graft versus Host Disease Patients.
Gerner, Bettina; Aghai-Trommeschlaeger, Fatemeh; Kraus, Sabrina; Grigoleit, Götz Ulrich; Zimmermann, Sebastian; Kurlbaum, Max; Klinker, Hartwig; Isberner, Nora; Scherf-Clavel, Oliver.
Afiliación
  • Gerner B; Institute for Pharmacy and Food Chemistry, University of Würzburg, 97074 Würzburg, Germany.
  • Aghai-Trommeschlaeger F; Department of Internal Medicine II, University Hospital Würzburg, Oberdürrbacher Strasse 6, 97080 Würzburg, Germany.
  • Kraus S; Department of Internal Medicine II, University Hospital Würzburg, Oberdürrbacher Strasse 6, 97080 Würzburg, Germany.
  • Grigoleit GU; Department of Internal Medicine II, University Hospital Würzburg, Oberdürrbacher Strasse 6, 97080 Würzburg, Germany.
  • Zimmermann S; Institute for Pharmacy and Food Chemistry, University of Würzburg, 97074 Würzburg, Germany.
  • Kurlbaum M; Core Unit Clinical Mass Spectrometry, Division of Endocrinology and Diabetology, Department of Internal Medicine I, University Hospital Würzburg, 97070 Würzburg, Germany.
  • Klinker H; Department of Internal Medicine II, University Hospital Würzburg, Oberdürrbacher Strasse 6, 97080 Würzburg, Germany.
  • Isberner N; Department of Internal Medicine II, University Hospital Würzburg, Oberdürrbacher Strasse 6, 97080 Würzburg, Germany.
  • Scherf-Clavel O; Institute for Pharmacy and Food Chemistry, University of Würzburg, 97074 Würzburg, Germany.
Pharmaceutics ; 14(12)2022 Nov 22.
Article en En | MEDLINE | ID: mdl-36559050

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmaceutics Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmaceutics Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza